Magazine
What’s so controversial about microdosing?
The incredible mainstream press microdosing has received has managed to avoid many discussions.
Brett Greene is a founder, director, and Chief Strategy Officer of Adelia Therapeutics.
Magazine
The incredible mainstream press microdosing has received has managed to avoid many discussions.
Magazine
Icaros: A Vision opens Friday, May 19th 2017 at Metrograph in NYC, followed by a national rollout in several cities in the U.S. and overseas.
Magazine
What if honest drug education, harm reduction, long term integration, and acknowledging risks, took the place of propaganda?